0

Journal Articles

in Thromboembolism/Anticoagulation
 21-40 of 150 Articles
Clinical Crossroads |  December 07, 2011
Antiplatelet and Anticoagulant Therapy in Patients With Gastrointestinal Bleeding:  An 86-Year-Old Woman With Peptic Ulcer Disease
Majid A. Almadi, MBBS, FRCPC, MSc(Epi); Alan Barkun, MDCM, FRCPC, MSc(Epi); James Brophy, MEng, MD, FRCPC, PhD
JAMA. 2011;306(21):2367-2374. doi:10.1001/jama.2011.1653.
INCLUDES: CME , Supplemental Content
Capitol Health Call |  November 09, 2011
Foreign Drug Supply Chain
Mike Mitka
JAMA. 2011;306(18):1970. doi:10.1001/jama.2011.1603.
Health Agencies Update |  October 26, 2011
Blood Clot Risk
Bridget M. Kuehn
JAMA. 2011;306(16):1750. doi:10.1001/jama.2011.1538.
Medical News and Perspectives |  August 24, 2011
As Production Goes Global, Drug Supply Faces Greater Risks to Safety, Quality
Bridget M. Kuehn
JAMA. 2011;306(8):811-813. doi:10.1001/jama.2011.1194.
Capitol Health Call |  July 13, 2011
Lobbying Efforts Questioned
Mike Mitka
JAMA. 2011;306(2):145. doi:10.1001/jama.2011.923.
Capitol Health Call |  April 13, 2011
Heparin Frustrations
Mike Mitka
JAMA. 2011;305(14):1402. doi:10.1001/jama.2011.416.
Clinical Crossroads |  April 06, 2011
Long-term Management of Venous Thromboembolism:  A 61-Year-Old Woman With Unprovoked Venous Thromboembolism
Kenneth A. Bauer, MD
JAMA. 2011;305(13):1336-1345. doi:10.1001/jama.2011.361.
INCLUDES: CME
Medical News & Perspectives |  January 05, 2011
New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
Mike Mitka
JAMA. 2011;305(1):25-26. doi:10.1001/jama.2010.1894.
Original Contribution |  November 10, 2010 FREE
Automated Surveillance to Detect Postprocedure Safety Signals of Approved Cardiovascular Devices
Frederic S. Resnic, MD, MSc; Thomas P. Gross, MD, MPH; Danica Marinac-Dabic, MD, PhD; et al.
JAMA. 2010;304(18):2019-2027. doi:10.1001/jama.2010.1633.
INCLUDES: , Supplemental Content
Original Contribution |  September 22, 2010 FREE
Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux:  The FUTURA/OASIS-8 Randomized Trial
The FUTURA/OASIS-8 Trial Group*
JAMA. 2010;304(12):1339-1349. doi:10.1001/jama.2010.1320.
INCLUDES: , Supplemental Content
Medical News & Perspectives |  August 25, 2010
FDA Approves Generic Enoxaparin
Rebecca Voelker
JAMA. 2010;304(8):844. doi:10.1001/jama.2010.1195.
The Rational Clinical Examination |  July 07, 2010
Can This Patient Read and Understand Written Health Information?
Benjamin J. Powers, MD, MHS; Jane V. Trinh, MD; Hayden B. Bosworth, PhD
JAMA. 2010;304(1):76-84. doi:10.1001/jama.2010.896.
INCLUDES: CME , Supplemental Content
Capitol Health Call |  June 09, 2010
Heparin Contamination
Mike Mitka
JAMA. 2010;303(22):2241. doi:10.1001/jama.2010.721.
Clinical Review |  February 03, 2010 FREE
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound:  A Systematic Review and Meta-analysis
Stacy A. Johnson, MD; Scott M. Stevens, MD; Scott C. Woller, MD; et al.
JAMA. 2010;303(5):438-445. doi:10.1001/jama.2010.43.
INCLUDES: CME , Supplemental Content
Editorial |  February 03, 2010
Evidence-Based Medicine Requires Appropriate Clinical Context
Robert A. McNutt, MD, PhD; Edward H. Livingston, MD
JAMA. 2010;303(5):454-455. doi:10.1001/jama.2010.47.
Medical News and Perspectives |  November 11, 2009
New Standards Reduce Heparin Potency
Rebecca Voelker
JAMA. 2009;302(18):1956. doi:10.1001/jama.2009.1615.
JAMA Patient Page |  October 14, 2009 FREE
Lung Complications After Surgery
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2009;302(14):1610. doi:10.1001/jama.302.14.1610.
INCLUDES: , Supplemental Content
Clinical Review |  June 17, 2009 FREE
Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation:  A Systematic Review
Jodi B. Segal, MD, MPH; Daniel J. Brotman, MD; Alejandro J. Necochea, MD, MPH; et al.
JAMA. 2009;301(23):2472-2485. doi:10.1001/jama.2009.853.
INCLUDES: CME
Preliminary Communication |  May 06, 2009 FREE
Microalbuminuria and Risk of Venous Thromboembolism
Bakhtawar K. Mahmoodi, BSc; Ron T. Gansevoort, MD, PhD; Nic J. G. M. Veeger, MSc; et al.
JAMA. 2009;301(17):1790-1797. doi:10.1001/jama.2009.565.
Commentary |  March 11, 2009
The CMS Ruling on Venous Thromboembolism After Total Knee or Hip Arthroplasty:  Weighing Risks and Benefits
Michael B. Streiff, MD; Elliott R. Haut, MD
JAMA. 2009;301(10):1063-1065. doi:10.1001/jama.301.10.1063.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  April 1, 2013
Use of Glucocorticoids and Risk of Venous Thromboembolism:  A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir, BSc; Erzsébet Horváth-Puhó, MSc, PhD; Olaf M. Dekkers, MD, PhD, MSc, MA; et al.
JAMA Internal Medicine
In This Issue of JAMA Internal Medicine  |  May 13, 2013
In This Issue of JAMA Internal Medicine
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?
Kristian B. Filion, PhD; Jonathan Assayag, MSc; Laurent Azoulay, PhD
JAMA Internal Medicine
Editor's Correspondence  |  May 13, 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply
Daniel M. Witt, PharmD; Thomas Delate, PhD; Mark A. Crowther, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems